SCHEMBL7032445

SCHEMBL7032445

CC(C)OC(=O)c1scc(Br)c1S(=O)(=O)Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.36
CA1 P00915 5/20 0.36
CA2 P00918 5/20 0.36
CA9 Q16790 5/20 0.36
COMT P21964 1/20 0.36
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
LMNA P02545 1/20 0.35
CA7 P43166 4/20 0.33
CA14 Q9ULX7 4/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
GSK3B P49841 1/20 0.33
KDM4E B2RXH2 2/20 0.32
POLB P06746 2/20 0.32
GAA P10253 1/20 0.31
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7028654 0.86 CA2 (0.44) CA12CA1CA2CA9COMT
SCHEMBL7031174 0.85 COMT (0.36) CA12CA1CA2CA9COMT
SCHEMBL7030429 0.85 ALDH1A1 (0.38) CA12CA1CA2CA9COMT
SCHEMBL7031980 0.84 COMT (0.35) CA12CA1CA2CA9COMT
SCHEMBL7029041 0.83 KDM4E (0.44) LMNAKDM4EPOLBMAPT
SCHEMBL7029160 0.82 PRKCI (0.38) CA12CA1CA2CA9COMT
SCHEMBL7023383 0.82 MAPK8 (0.34) CA12CA1CA2CA9COMT
SCHEMBL7029060 0.81 LMNA (0.33) CA12CA1CA2CA9COMT
SCHEMBL7027264 0.80 ADORA2B (0.34) CA12CA1CA2CA9COMT
SCHEMBL8559545 0.79 CA12 (0.34) CA12CA1CA2CA9COMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1232505-C Substituted sulfonamido (thio) carbonyl compounds BAYER AG (DE) 2005-12-21 CN disclosed
CN-1439631-A Substituted sulfonamido (thio) carbonyl compounds BAYER AG (DE) 2003-09-03 CN disclosed
US-20030162979-A1 Substituted sulphonylamino(thio)carbonyl compounds MULLER KLAUS-HELMUT (DE) 2003-08-28 US disclosed
CN-1105717-C Substituted sulfonamido (thio) carbonyl compounds BAYER AG (DE) 2003-04-16 CN disclosed
US-6441195-B1 2-ALKOXYCARBONYL-3-SULPHONAMIDE, SULPHONYL ISOCYANATE OR SULPHONYL ISOTHIOCYANATE-THIOPHENES; PRE- OR POSTEMERGENCE HERBICIDES; EFFICIENCY BAYER AKTIENGESELLSCHAFT (DE) 2002-08-27 US disclosed
EP-0859774-B1 SUBSTITUTED SULPHONYLAMINO (THIO)CARBONYL COMPOUNDS AS HERBICIDES BAYER AG (DE) 2002-04-03 EP disclosed
US-6180567-B1 REACTING 2-ALKOXYCARBONYL-BENZENESULFONAMIDE DERIVATIVE WITH 1,2,4-(1H)TRIAZOLE-5-(THI)ONE DERIVATIVE BAYER AKTIENGESELLSCHAFT (DE) 2001-01-30 US disclosed
CN-1207099-A Substituted sulfonamido (thio) carbonyl compounds BAYER AG (DE) 1999-02-03 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162979-A1 Substituted sulphonylamino(thio)carbonyl compounds CBR3, CTH, CBR1 CA12 1571/4885CA1 1037/4885CA2 248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.